Evaluation of a Patient 'nudge' on Engagement in Lung Cancer Screening

NCT ID: NCT06474611

Last Updated: 2025-02-25

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 894 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-03-26
• Study Completion Date: 2024-12-31

Brief Summary

The purpose of this quality improvement project is to conduct and evaluate the effect of sending an electronic reminder message to patients who qualify for lung cancer screening, haven't had a screening previously, and who have an upcoming scheduled appointment with their doctor.

Detailed Description

United States Preventive Services Task Force (USPSTF) lung cancer screening (LCS) guidelines recommend LCS for those aged 50-80 with at least 20 pack-years smoking history, who currently smoke or quit within the last 15 years. In 2023, our study team found that there are approximately 6,000 - 8,000 Kaiser Permanente Colorado (KPCO) members who are unscreened and eligible for lung cancer screening (LCS). In support of KP's Population Health priority initiative to expand lung cancer screening participation for those who are eligible, our study team was selected to move this work forward in 2024 with feasible implementation opportunities for the KPCO LCS Operational/Institute for Health Research partnership at its core. The primary objective of this project is to conduct and evaluate a randomized quality improvement pragmatic intervention of a 2-arm electronic message outreach to unscreened LCS members who are eligible for LCS and who have an upcoming scheduled Primary Care Provider (PCP) visit.

Conditions

Lung Cancer

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: OTHER
• Blinding Strategy: NONE

Study Groups

Birth year = odd

No intervention, care as usual

Group Type: NO_INTERVENTION

No interventions assigned to this group

Birth year = even AND active on KP.org

Has an upcoming primary care visit, qualifies for lung cancer screening based on USPSTF criteria, receives an electronic letter via KP.org informing that they qualify for LCS and reminding to talk to PCP about LCS at next visit.

Group Type: EXPERIMENTAL

Patient nudge

Intervention Type: BEHAVIORAL

Patient receives an electronic or paper letter 'nudge' to talk to dr about LCS.

Birth year = even AND not active on KP.org

Has an upcoming primary care visit, qualifies for LCS based on USPSTF criteria, receives a mailed letter informing that they qualify for LCS and reminding to talk to provider about LCS at next visit.

Group Type: EXPERIMENTAL

Patient nudge

Intervention Type: BEHAVIORAL

Patient receives an electronic or paper letter 'nudge' to talk to dr about LCS.

Interventions

Patient nudge

Patient receives an electronic or paper letter 'nudge' to talk to dr about LCS.

Intervention Type: BEHAVIORAL

Eligibility Criteria

Exclusion Criteria

• None

• Minimum Eligible Age: 50 Years
• Maximum Eligible Age: 80 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Kaiser Permanente

OTHER

Sponsor Role: lead

Responsible Party

Debra Ritzwoller

Senior Investigator - Economics and Cancer Research

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Debra Ritzwoller, PhD

Role: PRINCIPAL_INVESTIGATOR

Kaiser Permanente

Locations

Kaiser Permanente

Aurora, Colorado, United States

Countries

United States

Other Identifiers

IMP_LungCancerScreen

Identifier Type: -

Identifier Source: org_study_id